Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

NCT04003857 is registered in ClinicalTrials.gov with Medipost Co Ltd. as lead sponsor.

NCT NCT04003857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04003857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
Lead sponsor
Medipost Co Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 5, 2019
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bpd, bronchopulmonary dysplasia